Literature DB >> 25922138

The utility of bioimpedance analysis for monitoring the children with nutcracker syndrome.

Sevgi Yavuz1, Aysel Kıyak2, Ali Er3, Orhan Korkmaz4.   

Abstract

UNLABELLED: We aimed to evaluate anthropometric and bioimpedance analysis (BIA) indices of children with nutcracker syndrome (NCS). Eighteen patients and 20 age-gender matched controls were enrolled. Weight, height, body mass index (BMI), mid-arm circumference (MAC), waist circumference (WC), waist/hip ratio measurements, and BIA results were assessed. Laboratory parameters and Doppler sonographic findings were recorded. The weight, BMI, MAC, WC, body fat z scores, and waist/hip ratio were significantly lower in patients than in controls (p < 0.05). Serum creatinine (Scr), albumin, HDL cholesterol, and urine protein (Up) were significantly increased in NCS patients compared to controls (p < 0.05). On multivariate analysis, body fat z score was independently related to Up and the degree of superior mesenteric artery (SMA) angle (beta = -0.965, p = 0.018 and beta = 0.841, p = 0.04, respectively).
CONCLUSION: NCS might be considered in slim proteinuric patients with unproven etiology. Serial anthropometric measurements and BIA analysis would estimate the severity of entrapment in LRV. Long-term follow-up of Scr might be required in NCS. WHAT IS KNOWN: • Nutcracker syndrome (NCS) is very rare and characterized by the compression of LRV between aorta and SMA. What is new: • Patients with NCS have a slimmer body feature with lower anthropometric and BIA indices. • Fat percentage indicates the degree of LRV entrapment and amount of proteinuria in NCS.

Entities:  

Keywords:  Anthropometry; Aortomesenteric angle; Body fat; Nutcracker syndrome; Proteinuria

Mesh:

Year:  2015        PMID: 25922138     DOI: 10.1007/s00431-015-2535-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  Current trends in the diagnosis and management of renal nutcracker syndrome: a review.

Authors:  K Ahmed; R Sampath; M S Khan
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-01-23       Impact factor: 7.069

3.  Diagnosis of nut-cracker phenomenon using renal Doppler ultrasound in orthostatic proteinuria.

Authors:  B S Cho; Y M Choi; H H Kang; S J Park; J W Lim; T Y Yoon
Journal:  Nephrol Dial Transplant       Date:  2001-08       Impact factor: 5.992

4.  Factors affecting spontaneous resolution of hematuria in childhood nutcracker syndrome.

Authors:  Jae Il Shin; Jee Min Park; Soon Min Lee; Youn Ho Shin; Ji Hong Kim; Jae Seung Lee; Myung Joon Kim
Journal:  Pediatr Nephrol       Date:  2005-03-17       Impact factor: 3.714

5.  ACE inhibition can improve orthostatic proteinuria associated with nutcracker syndrome.

Authors:  Tae-Sun Ha; Eun-Ju Lee
Journal:  Pediatr Nephrol       Date:  2006-08-11       Impact factor: 3.714

Review 6.  Nutcracker syndrome: an underdiagnosed cause for hematuria?

Authors:  H E Hanna; R N Santella; E T Zawada; T E Masterson
Journal:  S D J Med       Date:  1997-12

7.  The nutcracker syndrome: an uncommon cause of haematuria.

Authors:  K R Shaper; J E Jackson; G Williams
Journal:  Br J Urol       Date:  1994-08

8.  Cross-sectional reference values for mid-upper arm circumference, triceps skinfold thickness and arm fat area of Turkish children and adolescents.

Authors:  Ahmet Ozturk; Nurten Budak; Betul Cicek; M Mumtaz Mazicioglu; Fahri Bayram; Selim Kurtoglu
Journal:  Int J Food Sci Nutr       Date:  2009-06       Impact factor: 3.833

9.  Role for angiotensin II in an overt functional proteinuria.

Authors:  T Yoshioka; T Mitarai; V Kon; W M Deen; H G Rennke; I Ichikawa
Journal:  Kidney Int       Date:  1986-10       Impact factor: 10.612

10.  Nutcracker and SMA syndromes: What is the normal SMA angle in children?

Authors:  O J Arthurs; U Mehta; P A K Set
Journal:  Eur J Radiol       Date:  2012-05-12       Impact factor: 3.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.